State CT
Clinical Trials in Connecticut
Recruiting clinical trials with at least one study location in Connecticut. Data updated daily from ClinicalTrials.gov.
Top Conditions in Connecticut
Frequently Asked Questions — Clinical Trials in Connecticut
How many clinical trials are currently recruiting in Connecticut?
ClinicalMetric currently tracks 201 actively recruiting clinical trials with at least one location in Connecticut. The total number of registered studies—including active but not currently enrolling trials—is 201. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Connecticut?
Connecticut hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Alcohol Use Disorder, Advanced Solid Tumors, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Connecticut serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Connecticut?
To join a clinical trial in Connecticut, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Connecticut maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Connecticut
NCT03488693 Phase 3
Recruiting
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Condition
Breast Cancer
Enrollment
2,140 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
NCT06423430 N/A
Recruiting
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
Condition
Treatment Resistant Depression
Enrollment
100 pts
Location
United States
Sponsor
Abbott Medical Devices
NCT06731764 Phase 2, Phase 3
Recruiting
Novel Approaches to the Treatment of Hypothyroidism
Condition
Hypothyroidism
Enrollment
90 pts
Location
United States
Sponsor
UConn Health
NCT04968834 N/A
Recruiting
Protocol For Genomically Profiling, Collecting, Archiving And Distributing Blood...
Condition
Leukemia
Enrollment
300 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
NCT05465538 Phase 1, Phase 2
Recruiting
SV2A in Older Adults
Condition
Cannabis Use
Enrollment
24 pts
Location
United States
Sponsor
Yale University
NCT05037968 N/A
Recruiting
MagnetOs Flex Matrix Compared to Trinity Elite Mixed With Local Autograft in Pat...
Condition
Degenerative Disc Disease
Enrollment
100 pts
Location
United States
Sponsor
Kuros Biosurgery AG
NCT06578247 Phase 3
Recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-I...
Condition
Leukemia
Enrollment
700 pts
Location
United States, Australia, Austria
Sponsor
Daiichi Sankyo
NCT06393738 Phase 1
Recruiting
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
Condition
Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL)
Enrollment
255 pts
Location
United States, Canada, Denmark
Sponsor
Arvinas Inc.
NCT06526143 N/A
Recruiting
M2VA Pain Care Pathway
Condition
Pain
Enrollment
1,800 pts
Location
United States
Sponsor
Yale University
NCT07222267 Phase 1
Recruiting
An Investigational Study of BG-75202 Alone and in Combination With Other Therape...
Condition
Breast Cancer
Enrollment
86 pts
Location
United States, Australia, China
Sponsor
BeOne Medicines
NCT06854653 Phase 2
Recruiting
A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
Condition
CTCL
Enrollment
115 pts
Location
United States, Australia, France
Sponsor
Prescient Therapeutics, Ltd.
NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT05286892 N/A
Recruiting
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
Condition
Diabetes Mellitus, Type 1
Enrollment
128 pts
Location
United States
Sponsor
Louise Reagan
NCT07226895 Phase 1, Phase 2
Recruiting
A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT198...
Condition
Clinical High Risk for Psychosis (CHR)
Enrollment
150 pts
Location
United States
Sponsor
Monument Therapeutics Limited
NCT06867094 Phase 2
Recruiting
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerat...
Condition
Colitis Ulcerative
Enrollment
204 pts
Location
United States, Argentina, Australia
Sponsor
Sanofi
NCT06345729 Phase 3
Recruiting
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants Wit...
Condition
Non-small Cell Lung Cancer
Enrollment
600 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT04130503 N/A
Recruiting
The Recovery in Stroke Using PAP Study
Condition
Ischemic Stroke
Enrollment
360 pts
Location
United States
Sponsor
Yale University
NCT07441694 Phase 1
Recruiting
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Condition
Myeloproliferative Neoplasms
Enrollment
218 pts
Location
United States, Australia, Belgium
Sponsor
Incyte Corporation
NCT07040566 Phase 2
Recruiting
A Trial of Varenicline for E-cigarette Cessation
Condition
E-cigarette Use
Enrollment
326 pts
Location
United States
Sponsor
Yale University
NCT06888388 N/A
Recruiting
Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Brea...
Condition
Breast Cancer Surgery
Enrollment
4,700 pts
Location
United States, Australia, Belgium
Sponsor
Sir Mortimer B. Davis - Jewish
NCT07407023 N/A
Recruiting
PoRI Clinical Trial
Condition
Post Stroke
Enrollment
12 pts
Location
United States
Sponsor
Yale University
NCT06136559 Phase 3
Recruiting
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of I...
Condition
Chronic Lymphocytic Leukemia
Enrollment
1,200 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
NCT05796141 N/A
Recruiting
Becoming United in Lifestyle Decisions
Condition
Overweight and Obesity
Enrollment
736 pts
Location
United States
Sponsor
University of Connecticut
NCT05855200 Phase 3
Recruiting
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage ...
Condition
Colonic Neoplasms
Enrollment
892 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
NCT06540963 Phase 2
Recruiting
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Condition
Neuroblastoma
Enrollment
98 pts
Location
United States
Sponsor
Giselle Sholler
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology